| Year |
Citation |
Score |
| 2021 |
Mahoney M, Damalanka VC, Tartell MA, Chung DH, Lourenço AL, Pwee D, Mayer Bridwell AE, Hoffmann M, Voss J, Karmakar P, Azouz NP, Klingler AM, Rothlauf PW, Thompson CE, Lee M, et al. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34635581 DOI: 10.1073/pnas.2108728118 |
0.757 |
|
| 2021 |
Mahoney M, Damalanka VC, Tartell MA, Chung DH, Lourenco AL, Pwee D, Mayer Bridwell AE, Hoffmann M, Voss J, Karmakar P, Azouz N, Klingler AM, Rothlauf PW, Thompson CE, Lee M, et al. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Biorxiv : the Preprint Server For Biology. PMID 34131661 DOI: 10.1101/2021.05.06.442935 |
0.758 |
|
| 2020 |
Muz B, Puente Pdl, Shah S, Federico C, Azab F, King J, Fiala M, Tang R, Karmakar P, Vij R, Achilefu S, Azab AK. Abstract A27: Endothelial progenitor cells as drug-delivery Trojan horses for treatment and imaging of cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A27 |
0.38 |
|
| 2019 |
Karmakar P, Gaitonde V. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel, Switzerland). 6. PMID 30709019 DOI: 10.3390/Medicines6010021 |
0.694 |
|
| 2018 |
Damalanka VC, Han Z, Karmakar P, O'Donoghue AJ, La Greca F, Kim T, Pant S, Helander J, Klefström J, Craik CS, Janetka JW. Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology. Journal of Medicinal Chemistry. PMID 30571119 DOI: 10.1021/Acs.Jmedchem.8B01536 |
0.639 |
|
| 2018 |
Hossain MK, Vartak A, Karmakar P, Sucheck SJ, Wall KA. Augmenting vaccine immunogenicity through the use of natural human anti-rhamnose antibodies. Acs Chemical Biology. PMID 29916701 DOI: 10.1021/Acschembio.8B00312 |
0.702 |
|
| 2018 |
Kotagiri N, Cooper ML, Rettig M, Egbulefu C, Prior J, Cui G, Karmakar P, Zhou M, Yang X, Sudlow G, Marsala L, Chanswangphuwana C, Lu L, Habimana-Griffin L, Shokeen M, et al. Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nature Communications. 9: 275. PMID 29348537 DOI: 10.1038/S41467-017-02758-9 |
0.367 |
|
| 2016 |
Han Z, Harris PK, Karmakar P, Kim T, Owusu BY, Wildman SA, Klampfer L, Janetka JW. α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer. Chemmedchem. PMID 26889658 DOI: 10.1002/Cmdc.201500600 |
0.77 |
|
| 2016 |
Liu F, Han Z, Karmakar P, Li T, Janetka JW, Lai A. DDIS-10. TARGETING HGF/MET IN GBM BY RESTORING SPINT2 FUNCTION Neuro-Oncology. 18: vi49-vi49. DOI: 10.1093/Neuonc/Now212.201 |
0.711 |
|
| 2016 |
Han Z, Harris PKW, Karmakar P, Kim T, Owusu BY, Wildman SA, Klampfer L, Janetka JW. Back Cover: α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer (ChemMedChem 6/2016) Chemmedchem. 11: 640-640. DOI: 10.1002/Cmdc.201600124 |
0.75 |
|
| 2015 |
Karmakar P, Lee K, Sarkar S, Wall KA, Sucheck SJ. Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of L-Rhamnose Targeting on Cellular Immune Responses. Bioconjugate Chemistry. PMID 26595674 DOI: 10.1021/Acs.Bioconjchem.5B00528 |
0.691 |
|
| 2014 |
Long DE, Karmakar P, Wall KA, Sucheck SJ. Synthesis of α-L-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies. Bioorganic & Medicinal Chemistry. 22: 5279-89. PMID 25172148 DOI: 10.1016/J.Bmc.2014.08.002 |
0.616 |
|
| 2011 |
Karmakar P, Talan RS, Sucheck SJ. Mixed-phase synthesis of glycopeptides using a N-peptidyl-2,4-dinitrobenzenesulfonamide-thioacid ligation strategy. Organic Letters. 13: 5298-301. PMID 21916403 DOI: 10.1021/Ol202163E |
0.666 |
|
| Show low-probability matches. |